HOME
FONDAZIONE
STUDI CLINICI
APPUNTAMENTI
CONTENUTI
NEWS
CONTATTI
More
A PHASE II RANDOMIZED TRIAL COMPARING A COMBINATION OF ABRAXANE AND GEMCITABINE VERSUS GEMCITABINE ALONE AS FIRST LINE TREATMENT IN LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER